| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 12.209 | 36.243 | 49.474 | 48.423 | 51.345 | 53.525 | 47.293 | 23.889 |
| Total Income - EUR | - | - | 12.209 | 36.243 | 49.474 | 48.423 | 51.345 | 53.525 | 47.293 | 23.889 |
| Total Expenses - EUR | - | - | 12.093 | 39.272 | 43.547 | 49.383 | 46.362 | 49.191 | 42.662 | 19.830 |
| Gross Profit/Loss - EUR | - | - | 116 | -3.029 | 5.928 | -960 | 4.983 | 4.334 | 4.630 | 4.059 |
| Net Profit/Loss - EUR | - | - | -76 | -3.391 | 5.433 | -1.407 | 4.480 | 3.880 | 4.114 | 3.446 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Niosib Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 7.050 | 6.904 | 14.731 | 14.203 | 10.102 | 14.625 | 18.219 | 19.680 |
| Inventories | - | - | 5.459 | 1.799 | 732 | 6.660 | 1.333 | 5.239 | 11.762 | 7.585 |
| Receivables | - | - | 706 | 0 | 182 | 103 | 0 | 4.056 | 64 | 3.362 |
| Cash | - | - | 884 | 5.105 | 13.817 | 7.441 | 8.769 | 5.331 | 6.393 | 8.733 |
| Shareholders Funds | - | - | -33 | -3.423 | 2.076 | 629 | 5.095 | 8.987 | 13.073 | 16.447 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 7.084 | 10.327 | 12.655 | 13.574 | 5.007 | 5.638 | 5.146 | 3.233 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Niosib Impex Srl